 |
 |
 |
 |
April 24th,2009 |
|||
|
2009 Pharma Pricing & Market Access Outlook Pharmerit will be present at the upcoming Pharma Pricing and Market Access Outlook 2009 in London, April 29-30th. This congress offers a great opportunity for sharing knowledge about health policy impacting drug pricing and reimbursement and for discussing how market access can be supported by HTA. Please feel free to visit us at our booth!
Recent Publications We are glad to announce that our Bayesian research has been published in Haemophilia (link to PDF). The manuscript describes a Bayesian meta-regression that combines published efficacy data of rVIIa and APCC. An article published in BMC Health Services Research, quantifies the possible HE consequences of generic substitution in patients with schizophrenia on Risperidone in Germany (link to PDF).
Newsletter This newsletter intends to inform our clients about interesting health economic topics, upcoming events and latest news in the field of health economics and outcomes research. We hope our newsletter provides you with useful and interesting information. If you have any suggestions or other questions, please enail us at
Unsubscribe
If you do not wish to receive our newsletter again, you can unsubscribe by using the link in the e-mail version of the newsletter.
|
Introduction to Pharmerit International
Pharmerit International is a research organization based in Rotterdam in the Netherlands, Bethesda, MD, USA, and York in the United Kingdom. Pharmerit helps define, build and communicate your product’s clinical, humanistic and economic value via a wide range of research activities, including:
For more background information, please visit our website. ISPOR Meeting, Orlando, May 16-20, 2009  The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting offers an ideal opportunity for sharing knowledge and new developments, and discussing them with others in the field of health economics and outcomes research. Are you interested in what research we are conducting? Please visit our booth (no. 84-85), or visit one of the Pharmerit-sponsored Internet Access Stations.
Pharmerit’s Staff Contributions to ISPOR 14th Annual International Meeting in Orlando, FL, USA:
Educational Symposium Saturday May 16th, 17:00 - 18:00 Valuing more complex descriptive systems: DCE and TTO 21st Century solutions: EQ-5D in the digital age
Short Course Saturday May 16th, 13:00 - 17:00 Modeling: Design and structure of a model
Research Presentations Session I, Monday May 18th, 15:45 – 16:45 Research on Methods - Utility methods: The value of added life years as a function of age, prognosis and quality of life (UT3) Session III, Tuesday May 19th, 8:30 - 9:30 Modeling Studies: Impact of including cardiovascular and respiratory outcomes on estimates of clinical and economic benefits of influenza vaccination in the U.S. elderly population (MO1)
Poster Presentations Session I, Monday May 18th, 18:00 - 19:00 Methods and Concepts: A transmission-dynamic model to predict the indirect benefits of infant vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) to older populations (PMC39) Muscular-Skeletal disorders: Cost-effectiveness of the use of Etanercept vs. Rituximab in patients with rheumatoid arthritis in Mexico (PMS22) Session II, Tuesday May 19th, 18:00 - 19:00 Infection: Modeling the inpatient and outpatient costs of methicillin- resistant staphylococcus aureus (MRSA) complicated skin and soft tissue infections (cSSTI): a comparison of Linezolid, Vancomycin, Daptomycin and Tigecycline (PIN11) Session III, Wednesday May 20th, 9:30 - 10:30 Urinary/Kidney Disorders: Cost-effectiveness analysis of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder: application to the United Kingdom (PUK9) |
||
 |